An Experimental Mouse Model for Hepatitis C Virus

DOI Web Site Web Site 1 Citations 87 References
  • KIMURA Kiminori
    Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science Division of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
  • KOHARA Michinori
    Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science

Bibliographic Information

Other Title
  • Frontiers of model animals for human diseases: An experimental mouse model for hepatitis C virus

Search this article

Abstract

Chronic hepatitis C virus (HCV) infection affects approximately 170 million people and is a major global health problem because infected individuals can develop liver cirrhosis and hepatocellular carcinoma. Despite significant improvements in antiviral drugs, only around 50% of treated patients with genotype 1 and 4 demonstrate HCV clearance. Unfortunately, an anti-HCV vaccine is still not available. To progress treatment of HCV, it is necessary to understand the mechanism(s) by which HCV infects hepatocytes, and how the host immune response prevents the spread of the virus. Because HCV infects only humans and chimpanzees, it is difficult to evaluate immune response mechanisms, and the effects of chemicals and new technologies on these response mechanisms. These difficulties underline the importance of establishing a small HCV-infected animal model. This review focuses on the progress made in recent years towards the development of an experimental mouse model for HCV.<br>

Journal

  • Experimental Animals

    Experimental Animals 60 (2), 93-100, 2011

    Japanese Association for Laboratory Animal Science

Citations (1)*help

See more

References(87)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top